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ABSTRACT
Objectives: To investigate the views and experiences
of patients regarding their glaucoma follow-up,
particularly towards the type and frequency of visual
field (VF) testing.
Design: A qualitative investigation using focus groups.
The group discussion used broad open questions
around the topics in a prompt guide relating to
experiences of glaucoma follow-up, and in particular,
VF monitoring. All the groups were taped, transcribed
and coded using manual and computer-aided methods.
Setting: Three National Health Service (NHS) hospitals
in England; two focus groups took place at each
hospital.
Participants: 28 patients (mean (SD) age: 74 (9)
years; 54% women) diagnosed with glaucoma for at
least 2 years. Each focus group consisted of 3–6
patients.
Primary and secondary outcomes: (1) Attitudes
and experiences of patients with glaucoma regarding
VF testing. (2) Patients’ opinions about successful
follow-up in glaucoma.
Results: These patients did not enjoy the VF test but
they recognised the importance of regular monitoring
for preserving their vision. These patients would agree
to more frequent VF testing on their clinician’s
recommendation. A number of themes recurred
throughout the focus groups representing perceived
barriers to follow-up care. The testing environment,
waiting times, efficiency of appointment booking and
travel to the clinic were all perceived to influence the
general clinical experience and the quality of
assessment data. Patients were also concerned about
aspects of patient–doctor communication, and often
received little to no feedback about their results.
Conclusions: Patients trust the clinician to make the
best decisions for their glaucoma follow-up. However,
patients highlighted a number of issues that could
compromise the effectiveness of VF testing. Addressing
patient-perceived barriers could be an important step
for devising optimal strategies for follow-up care.
INTRODUCTION
Glaucoma is a group of chronic diseases of
the optic nerve that, if not managed effect-
ively, could lead to visual impairment or
blindness. Currently, the only modiﬁable risk
factor for disease worsening (progression) in
glaucoma is reduction of intraocular pressure
(IOP). A variety of different approaches to
IOP lowering are available, meaning surveil-
lance of the patient is important in selecting
the correct intensity of treatment. Over half a
million people in the UK are thought to have
the condition, with clinics receiving over a
million outpatient visits annually.1 2 Since the
prevalence of glaucoma increases exponen-
tially with age, these ﬁgures can be expected
to increase dramatically with an ageing popu-
lation. Glaucoma monitoring, therefore,
represents a major workload for eye services
in the National Health Service (NHS).
Assessment of non-seeing or ‘blind’ areas
of the visual ﬁeld (VF) is central to the moni-
toring of visual function in glaucoma. The
VF is assessed by standard automated perim-
etry (SAP), a sophisticated automated instru-
ment. The test is carried out in a darkened
room and takes about 10 min per eye. In
short, a patient looks into the part of the
instrument that consists of a large semicircu-
lar bowl covering their entire ﬁeld of view.
The instrument presents a series of stimuli
(spots of light), one at a time, at a range of
contrast levels at varying locations in the VF
Strengths and limitations of this study
▪ This is the first qualitative study to examine
patients’ views of visual field monitoring using
focus groups.
▪ Focus groups took place at three selected hospi-
tals in the South of England; it is assumed that
the views expressed represent the experiences of
patients in a wider population.
▪ Not all patients approached by their ophthal-
mologist took part, but reasons for non-
participation were not monitored. Patients who
chose to volunteer may be more articulate, moti-
vated and opinionated than the general patient
population.
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while the patient ﬁxates on a central point. The patient
responds by clicking a button when a stimulus is
detected. This process yields a map of the seeing parts
of the patient’s ﬁeld of view; this map is subjected to stat-
istical analysis comparing a patient’s results to normative
values for people with healthy vision. These measure-
ments can be highly variable, and speed (rate) of VF
loss, determined from a series of measurements over a
period of time, varies considerably between treated indi-
viduals. The VF should, therefore, be monitored at
appropriate intervals in order to identify timely interven-
tion of more intensiﬁed treatment to preserve visual
function.3 Yet, evidence regarding how frequently VF
tests should be carried out to optimally detect disease
progression is limited. The National Institute of Care
Excellence (NICE) called for more research into exam-
ining the effectiveness of using different monitoring
intervals to detect disease progression in people with
glaucoma in 2009.1 Guidelines proposed by the
European Glaucoma Society (EGS) recommend that the
frequency of VF tests should be increased for newly diag-
nosed patients in order to better determine the speed of
VF progression. This notion is supported by research evi-
dence based on statistical analyses of retrospective data
which has indicated that three VF tests per year in the
ﬁrst 2 years of follow-up would be clinically useful for
identifying patients who are deteriorating at faster
rates.4–6 However, a recent multicentre audit of glau-
coma clinics in England indicated that most patients
have only about one VF test a year.7 In another recent
study, VF monitoring intervals assigned by clinicians (for
hypothetical patient scenarios) were shown to be highly
variable.8
Organisational and resource constraints in the current
NHS setting will impact on the feasibility of translating
research-supported guidelines for VF monitoring to
practice. Furthermore, the clinician ultimately drives
decision-making based on their own estimates of the
likelihood and speed of disease progression, and there-
fore their opinions towards the appropriateness of moni-
toring intervals will be important. At the same time,
establishing effective monitoring strategies for this
chronic condition likely also requires the input of the
patients themselves, especially if it equates to more clinic
visits. Care plans that place burdens on patients may
result in a reduced willingness to return for follow-up
and compromise the quality of the data obtained that is
subsequently relied on during management.9 10 Studies
have shown that the views of the clinician and the
patient regarding aspects of their condition are not
always aligned,11 12 implying the patient’s perspective
must also be considered. Nevertheless, there has been
limited use of patient-based research for improving glau-
coma care. A review of the literature found that most of
the studies use questionnaires to quickly gather informa-
tion about the perceptions of patients, usually with
regard to their perceived outcomes.13 However, ques-
tionnaires can be impersonal and subject to bias.14 15
Qualitative techniques, such as focus groups, offer an
alternative method of gathering information about what
a patient thinks and how they think or why they may
hold a particular view. Group interaction encourages
participants to explore and clarify individual and shared
perspectives and supports the participation of people
who may be reluctant to contribute their views in a
more formal one-to-one scenario.16 Focus groups have
been used in a small number of studies to examine the
general experiences of glaucoma patients at diagnosis,
their expectations and to identify potential barriers to
treatment adherence.10 17–19 However, there is limited
evidence regarding the opinions of patients about the
manner in which their vision loss is monitored.
Anecdotal evidence suggests that patients dislike per-
forming the VF test, and one quantitative study showed
that patients rate the VF test least favourably of all the
vision assessments.20 However, no study has interviewed
patients with glaucoma in detail about their perceptions
of the VF test and their follow-up care. The current
study, therefore, aims to shed light on the effectiveness
of glaucoma monitoring from the perspective of the
patient by exploring patient’s views and experiences via
focus groups. In particular, the study aims to establish
patients’ views about VF testing in glaucoma monitoring.
METHODS
Participants and methods
Focus groups took place between May 2012 and January
2013 in the following locations: The Queen Alexandra
Hospital NHS Trust in Portsmouth; Norfolk and
Norwich University Hospital NHS Foundation Trust in
Norwich and Moorﬁelds Eye Hospital NHS Foundation
Trust in London. The study was multicentred to reduce
the bias that might come from one geographical area
and to encompass healthcare trusts in urban and rural
locations. The sites were chosen because they were
involved in a wider programme work, of which the
current study was a component. There were two focus
groups at each site, with participants allocated to one of
the two groups at the corresponding hospital.
The study used purposeful sampling whereby a con-
sultant ophthalmologist at each participating eye hos-
pital selected suitable participants during their routine
eye check-up. Speciﬁcally, the participant was required
to be aged 60 years and over and to be an established
glaucoma patient who had been under review for at
least 2 years. These criteria were chosen to reﬂect the
age-related nature of disease and to ensure that partici-
pants had had sufﬁcient experience of VFs as part of
their glaucoma follow-up. The ophthalmologist gave
potential participants an information sheet, and inter-
ested people were asked to sign a form indicating they
were happy to be contacted by a researcher (it was
stressed that they were not obliged to participate). Each
consultant ophthalmologist approached 20 patients in
this way. One of the study investigators (HB) then
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contacted the patients with further information and
invited them to take part on one of the two speciﬁc
dates at the corresponding hospital. Those who declined
did so because they were not available on the speciﬁc
dates (no other reason was cited). Initially, ﬁve to six
patients were signed up to participate on each of the six
study dates. However, a small number (n=4) of patients
did not attend. A total of 28 participants (mean age
(SD) 74 (9) years; 54% women) eventually took part
across the six focus groups. Each group consisted of
three to six patients and included participants of both
genders.
Procedure
A topic guide was devised prior to beginning the study,
outlining broad question areas regarding general glau-
coma care, experiences of the VF test and opinions
about the VF test frequency. Study topics were informed
by an initial pilot exercise involving a discussion with two
patients with glaucoma, who also provided additional
verbal and written information about their experiences.
The topics included in the guide acted only as sugges-
tions; the wording of questions was not predetermined
and the order of the topics was not ﬁxed. Prompts were
used to introduce topic areas and encourage respon-
dents to elaborate but the onus was on participants to
supply the overall content of the discussion. Care was
taken to ensure that the questions were open and ‘non-
leading’, although more speciﬁc questioning was some-
times used to clarify a point made by a participant. If dis-
cussion went substantially off-topic, or one participant
was dominating the conversation, the interviewer would
reﬂect back to a previous topic and encourage other
participants to contribute their views.
Prior to the study, participants were informed that
they would be involved in “an open discussion about
(their) experiences in the glaucoma clinic, with special
attention to the visual tests (they) undertake”.
Participants were not explicitly aware of the emphasis on
VF testing, so as to avoid bias linked to the self-selection
of participants with strong views on this one topic. All
focus groups were conducted by one of the authors
(HB), a postdoctoral researcher who had a prior experi-
ence of qualitative research involving patients with glau-
coma.18 21 The interviewer and participants had no
prior knowledge of each other in a clinical or personal
context, so each focus group began with general intro-
ductions. Field notes were taken during the sessions to
aid later interpretation of the data, although note-taking
was purposely minimal so that the interviewer could be
fully attentive to the discussion. The focus groups lasted
between 60 and 75 min.
The study conformed to the Declaration of Helsinki
and written consent from all participants was obtained
prior to each focus group.
The study was designed and reported in accordance
with the Consolidated Criteria for Reporting Qualitative
Research (COREQ) for interviews and focus groups.22
Analysis
All focus groups were audiorecorded (with permission
from the participants). The dialogue from the record-
ings was later transcribed and reviewed by the investiga-
tors. In a small number of instances, certain words were
inaudible on the recordings due to excessive back-
ground noise, so ﬁeld notes were used to account for
any unclear information.
Data were analysed by two of the authors (HB and FCG)
independently using framework analysis23 as displayed in
table 1. Each investigator read and re-read the transcripts
and manually identiﬁed the key themes from the data in
addition to some example quotes to illustrate the main
points. One of the authors (FCG) was masked to the
emphasis on VF testing at this initial point of analysis,
although became aware following a subsequent discussion
about the key categories that had emerged during that
ﬁrst stage. The qualitative software package NVIVO V.10.2
(QSR International, Cambridge, Massachusetts, USA) was
used to organise the thematic framework by reﬁning and
condensing the categories that had been manually identi-
ﬁed and to identify additional themes for exploration. Any
differences of opinion regarding the meaning of sen-
tences or the importance of themes were discussed until a
consensus was reached.
FINDINGS
Data were initially indexed according to themes central
to the main research questions, such as opinions of the
VF test, current experience regarding the frequency of
VF testing and opinions about more frequent VF testing.
Throughout the analysis, a number of additional themes
emerged, often with their own subthemes; these gener-
ally related to speciﬁc areas perceived to affect the
follow-up experience, and included points relating to
clinical constraints (waiting times, booking appoint-
ments), travel to the clinic, the testing environment and
aspects of patient–clinician communication. The themes
and subthemes are summarised in ﬁgure 1.
Table 1 Framework technique used for data analysis
Framework technique
1. Familiarisation Reading and re-reading the
transcriptions
2. Identifying a
thematic framework
Condense data into categories
3. Indexing Codes systematically applied to
the data
4. Charting Re-arranging the data
according to the thematic
content in a way which allows
for a cross case and within
case analysis
5. Mapping and
interpretation
Interpretations and
recommendations
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Direct quotes taken from the transcripts are italicised.
These quotes were examples chosen to illustrate the key
themes that emerged from the focus groups. Excerpts
are annotated with a pseudonym for the corresponding
participant based on their gender (‘M’ or ‘F’) and the
order in which they spoke in the interview. The location
of the focus group and the session number (1 or 2) are
also shown for each quote.
VFs: opinions about testing
Test procedure
Patients expressed a dislike for the VF test. They found
the test time-consuming, old-fashioned and tiring.
Well the reason why I don’t like them: I don’t like the
dark, I don’t like conﬁned spaces and I don’t like having
one eye closed and having to concentrate, even if it’s for
just a couple of minutes, because then my mind
wanders… F1, Portsmouth 1
It seems a bit antiquated, pressing the buttons… it
doesn’t seem positive enough to me. F3 Norwich 2
I appreciate the need for it…but it’s so time consuming.
M2 London 1
Performance pressure
Many put pressure on themselves to perform the test
well, as they felt there could be a lot riding on their
performance.
There is pressure: I think it is because your eyes are so
important for everyday living, that, you know, you’re
frightened to [not do well]. F2 Portsmouth 1
There was a general appreciation that such testing was
vital to preserve their vision.
Well… obviously I’m very grateful that I’m being moni-
tored all… F4 London 1
mine has been 10 years and you think, well how long will
I have my sight? … My mum had lost her sight by then,
you know… F3 Norwich 2
Comparison with other tests
Patients found other tests used in their clinical monitor-
ing, such as visual acuity, IOP measurement and imaging
tests, less tiring and laborious. At the same time, some
patients felt the VF test was more ‘valuable’, providing
more reassurance that their condition was being
investigated.
[with] the [imaging] there’s just one person, one
machine and you, and it’s done and that’s it, it’s over…
within minutes. F3 Norwich 2
they look in your eyes to measure your pressure but when
you do that ﬁeld test, they see more…. F1 London 2
Frequency of VF testing
Current experience
The VF tests were usually performed once or twice a
year, either during or closely prior to the patient’s
general clinical appointment. Patients who visited the
clinic more frequently would have a VF test at only some
of their appointments. Some patients were often
unaware as to whether they would have a VF test during
their visit.
I mean they just say you’re going to come for your next
appointment in whatsoever, whatever time, but they don’t
say, ‘Oh, in that time you will be having a visual ﬁeld
check’, so that you know that you are going to have to be
that little bit longer… F2 Portsmouth 1
Opinions about more testing
When patients were asked whether they would be willing
to visit the clinic for VF testing more frequently, there
was a reluctant agreement. The test was viewed as a
Figure 1 Coding tree showing main themes and subthemes that emerged from the analysis, and how the categories relate to
each other.
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‘necessary evil’ and most were open to more frequent
testing if the clinician felt it would enhance their prog-
nosis, although there was scepticism as to how useful the
test actually was.
If it was necessary. F2 Portsmouth 2
You’d get on with it. M1 Portsmouth 2
If it helps the cause so be it. M2 Portsmouth 2
I don’t want to lose my sight, I’d come in whenever. F2
Portsmouth 2
If it holds it back for 10 years… I’m happy with another
10 years! M1 Norwich 2
That’s a problem with glaucoma, you can’t leave it for
too long. M2 London 2
I suppose I’d accept it because I would hope that the
reason for asking me was that they will get more informa-
tion from that, which obviously deals with the whole
problem but…I’m not really sure at all about how useful
they are. I mean is it just statistics or whatever? …I’m
sure they’re useful but I wonder in what proportion of
use they are compared to, you know, looking in the eye
and pressures and things…. F3 Norwich 2
Some patients associated more frequent testing with
worsening vision; therefore, being asked to attend for
more testing could lead to increased anxiety.
you’d think they’ve called me back ‘cause it’s going,
deteriorating. But I mean if they said to do it, I’ve always
done … because they’re doing the best for me…
F3 Norwich 2
Learning effect
One recurrent topic regarding VF testing was issues
relating to the learning effect, whereby performance
improves with increased testing. Some suggested that
more repeat testing would be helpful. However, the
repeated tests may only be worthwhile if they took place
at the beginning of their follow-up care.
interestingly I went and did one once and they said to
me, “this has improved from the last time” and I said
“well I think I’m just getting better at computer games”
… I think you do know what’s coming and you can
improve and I just feel more comfortable with doing it.
F1 Norwich 1
I think to do a ﬁeld test right at the beginning, and to
take that as being the deﬁnitive ﬁeld test is wrong…
because I think you need to do a test and think, and
revise it in your mind what you’ve done and then do it
again. M1 Portsmouth 2
There was some debate about the period of time
between VF tests.
I think you need to do a ﬁeld test and then perhaps a
month later do the second one. M1 Portsmouth 2
Well not if you have a long gap between them. F1
Norwich 2
I’ve got used to it now. F2 Norwich 2
I don’t think it’s any different really. F3 Norwich 2
Perceived issues and barriers for successful
follow-up care
Some additional themes emerged during the analysis,
highlighting a number of areas perceived to be import-
ant and potentially representing barriers to successful
follow-up.
Communication
VF instructions
Regardless of how long they had been attending the
glaucoma clinic, patients appreciated having the VF test
procedure fully explained to them. It was rare for a staff
member to stay with the patient throughout the test, but
on the occasions it did happen, patients found the
experience reassuring and felt the encouragement
helped their performance.
They say, “Have you done this before?” You say “Yes”. And
that’s it, you’re left there and eventually they say, “Have
you ﬁnished? M1 Portsmouth 2
I had one about three weeks ago and it was a young
nurse and it was a completely different experience. She
was professional, polite, kind; she told me exactly what
they were doing… it was almost a pleasant experience.
F1 Portsmouth 1
There was discussion about understanding the aspects
of the testing procedure and how the procedure was
explained. For example, some patients expressed uncer-
tainty and felt test pressure would inﬂuence their results.
Again, explanation and reassurance before and after the
test helped.
The staff told me: “don’t worry about missing [a light]
because it’ll come later”, so you know you get a second
chance. F1 Norwich 1
if in doubt press the button, don’t you? F1 Portsmouth 2
Explanation of results
Most patients said they had to speciﬁcally enquire about
their results to ﬁnd out information about their vision
and whether their condition had progressed since the
last appointment. Some patients felt intimidated to ask
the clinician for feedback as to how they had per-
formed, feeling they were being a nuisance or wasting
the clinician’s time.
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They never discuss the result of the ﬁeld test unless
I ask… M2 London 2
My wife always says “how did you get on?” and I say “I
don’t know”, and that’s one of the problems. M2
Portsmouth 2
I don’t think they’ve got time to listen to you, or they
don’t appear to, and I don’t know whether they would
listen…. You feel pathetic asking these questions. F3
Portsmouth 1
Patients may be more inclined to have the VF tests
more frequently should they be informed clearly about
what the results indicate about their prognosis.
I don’t mind how many times I do it providing I get a
result of the test at that time compared to what the previ-
ous one was. Is there any improvement? Is there any
downgrade? M1 Portsmouth 1
The patient–clinician relationship
The quality of relationship with the clinical staff and
aspects of patient–clinician communication also
emerged as key factors inﬂuencing perceptions of the
follow-up process.
An apparent lack of personalised care caused unease;
there was a sentiment that sometimes the clinician
simply looked at the eyes and failed to consider the
person’s individual needs.
You’re not a person, you know, you’ve just got eyes,
they’re just going to deal with that and that’s it. F3
Portsmouth 1
The experience was seen to be much more bearable if
they felt the staff member dealing with them was
empathic.
Even buying a chop, you know: if the butcher’s inter-
ested, it helps doesn’t it? M3 Norwich 1
The opportunity to spend more time with their con-
sultant ophthalmologist was a key factor that inﬂuenced
whether or not patients were open to visiting the clinic
more frequently.
Not [ just] for the ﬁeld test… But I wouldn’t mind
coming in more to see the doctor. M2 London 2
Testing environment
The testing environment was another important theme.
The dark room, especially if it was warm, made focusing
on the tests difﬁcult. Patients felt they performed better
in the morning when they were more alert. Ambient
noise in the room made it difﬁcult to concentrate; staff
members talking and performing the test at the same
time as several other patients all had deleterious effects.
I will also say that the staff chatter a lot, which is difﬁcult
for concentration; the doors open and close, there’s a lot
of noise. F1 Norwich 1
I ﬁnd it difﬁcult sometimes when people [move] about
behind you… M1 London 1
The times that I’ve had the visual ﬁeld test done in a
room where there’s just one [machine], I felt more conﬁ-
dent to do it; it was much quieter and more relaxed and
it seemed to be a lot quicker too. F3 Norwich 2
I think having the quieter atmosphere would generally
help I’m sure….just that feeling of slight calm, you can
relax more and then it probably would be a lot quicker
because maybe you’re not going to miss as many [lights]
as you haven’t got other distractions. F3 Norwich 2.
The idea was raised that routine VF testing could be
carried out in a more convenient location. Some
patients had previously visited a local optometrist to
carry out a VF test for the purpose of assessing their
legal ﬁtness to drive. On the positive side, patients liked
the convenience of doing so and described a better
testing environment. Conversely, they questioned the
competency of the staff, the quality of the equipment
and the information trail back to the hospital.
The principle of having routine tests done locally is
acceptable providing they are trained. M1 London 1
That way you would be there, dealt with by people you
know probably more intimately…you’re in a more
relaxed environment… M1 Norwich 1
I would be concerned about how often the machine was
calibrated to get an accurate reading. M2 London 1
Is the information going back to where it matters in my
notes? Things do get lost, and will someone actually look
at the test? M1 London 2
Some felt that they had built up a level of trust with
the hospital eye service and would therefore prefer to
have VFs conducted in this environment.
I’ve been here for quite a while now and I like coming to
them: I don’t want to go anywhere else. F1 London 2
I would feel the same because it’s a matter of trust. M2
London 2
Clinic constraints
Waiting times
Waiting times were a major concern at all locations. The
standard time taken per visit was estimated to be 2 h,
although the wait was often unpredictable. Established
patients were used to wait and tried not to let it affect
them but they still found the system frustrating. Patients
were scared of missing their slots and, therefore, would
not leave their seat in the waiting area.
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No way I’m going to nip off … especially as now I’m on
my own, no way…. just even nipping off to the [bath-
room] because you think, ‘He’s bound to call me. I can
sit here for an hour and he’ll call me the minute I go to
the [bathroom]. F2 Portsmouth 1
Although it was repeatedly acknowledged that the
clinics were very busy, which had the knock-on effect of
increased waiting times, patients felt that they were
getting adequate treatment overall. It was suggested that
there was a trade-off between longer waiting times and
higher quality treatment:
I think that’s a very fair price to pay for the fact that
you’re being dealt with in a UK centre of excellence.
There’s a trade-off in that you’re getting state of the art
treatment but the price is you’ve got to sit around for it.
M1 London 1
Travelling to the clinic
Several subthemes emerged including issues with long
distances to travel, avoiding rush hours, travel costs and
travelling alone.
I think the problem is because I live nearly an hour away,
for me the nearest hospital is an hour away… F2
Norwich 2
Taxi is the only way I can do it now. You know, I can get
to the station by bus and possibly with help to get on the
train but it’s not easy…. It’s horriﬁc, frightening. M2
London 1
Tiring journeys to the clinic and late clinic appoint-
ments were also sometimes perceived to have a negative
effect on VF test performance.
I think if you did the eye check later in the day, you
know, if your eyes were tired, it might make you feel [that
you] wouldn’t see so well…F2 Portsmouth 1
Scheduling appointments
The scheduling of appointments was a major concern:
often the systems were so overbooked that patients were
unable to make their next appointment at their clinic visit.
You can only make an appointment six weeks in advance.
You used to get a twelve month appointment letter just
after you had been for an appointment; now its six weeks
before you are due. M2 Norwich 1
Often patients would receive an appointment only to
have it cancelled just before the clinic was due to take
place. This was not only frustrating to people who had
made arrangements for their appointment, such as
asking a friend to accompany them or arranging cover
for sick spouses, but also it caused concern that their
appointment was to be at a much later date than the
clinician had originally requested.
So if you’ve been given a six month appointment and it’s
cancelled, and you’re not given another one, you ring up
and then they say “oh we can’t give you an appointment
now until October”. That was 10 months. Now if your
consultant says 6 [months] and it’s 10 and something’s
gone wrong with your vision in between, you have no way
of telling. F2 Portsmouth 2
PATIENT RECOMMENDATIONS
At the end of the focus groups, patients were asked to rec-
ommend changes to improve their follow-up care. The
recommendations were similar across all locations and
the most popular suggestions are displayed in table 2.
DISCUSSION
Data from this study support evidence from elsewhere
that patients ﬁnd VF testing more laborious and
demanding than other vision tests.20 Nevertheless,
patients were willing to complete more VF tests on the
guidance of their clinician, as ultimately they were pre-
pared to do whatever it took to preserve their vision.
Thus, patients may tolerate more frequent VF testing
during the ﬁrst 2 years of their follow-up care as recom-
mended by the research literature4 5 and some clinical
guidelines.24 Patients commented that it took time to
feel comfortable with the test procedure, and that mul-
tiple attempts were needed to gain an accurate represen-
tation of their vision. These viewpoints complement the
existing evidence showing that performance can
improve considerably during follow-up due to gaining
experience with the testing process.25
There were, however, a number of additional themes
that emerged from the data which identiﬁed areas that
could represent potential barriers to successful glau-
coma monitoring. Patients felt that the environment in
which they completed the VF test was linked to how well
they were able to perform the task, with staff members
talking loudly, the number of people in the room and
the time of day all listed as important interfering factors.
These views coincide with other evidence showing that
the environment, the technician and the time of day do
Table 2 Patient recommendations for improving follow-up
care
Patient recommendations
1. Less waiting and clinics running to time
2. Flexible booking and changing of appointments
3. To have a calmer, quieter environment in the visual
field room with fewer people doing the test at the same
time
4. To modernise the visual field test
5. To have more continuity of care by seeing the same
clinician at each visit
6. To receive better communication from the clinician
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have a signiﬁcant inﬂuence on measurement variability
from VF tests.26 Fatigue, a topic mentioned frequently
throughout the discussions, has also been shown to
affect performance as test duration increases.27
Patients highlighted the importance of effective task
communication for inﬂuencing their VF test perform-
ance. Prior evidence has shown that the quality of
instruction given before the VF test can signiﬁcantly
affect subsequent estimations of VF defect severity.28 29
Patients also felt that it was essential to have the task
explained to them properly, even if they had been
attending clinics for some time. Having a staff member
in the room while they carried out the test was found to
be reassuring. These ﬁndings reiterate the idea that
ensuring the task demands are communicated clearly
and effectively before every VF test, and being on hand
to alleviate any concerns or questions that the patient
may have, may help maximise the quality of the data
gained from the assessment.29–31
Other discussion points relating to communication
were also raised repeatedly throughout the focus groups.
Patients felt that many clinicians treated them as an ‘eye’
rather than a person, with those staff members who took
a more individualistic and empathic approach viewed
favourably. Notably, patients felt that they had to ask
explicitly about their results in order to learn details
about their own condition. Evidence has shown that that
the patient’s and clinician’s views of their condition are
not always aligned, which may be due to miscommunica-
tion or misinterpretation of key information on both
parts.32 By explaining the results in a clear, simple and
concise manner, the patient will inevitably improve their
understanding of their condition, which in turn could
inﬂuence how well they respond to important aspects of
their follow-up care. For instance, it has been shown that
the way in which clinicians communicate with the
patient can inﬂuence future adherence to medication.32
It has been suggested that clinicians underestimate the
importance of effective communication to the patient,11
and in one study, examining the patient’s expectations
for eye care, the emphasised areas were all related to
communication and interpersonal manner.33 Providing
better information about the purpose of VF testing,
what is required of the patient, and its results and
general prognosis could be vital for improving attend-
ance for VF tests or for the subsequent quality of data
obtained. Perhaps, developers of SAP ought to think
about ways in which the complex measurement of the
VF could be easily presented and communicated to
patients. It is important to note that some patients asso-
ciated more frequent testing with worsening vision,
which caused some distress. Thus, should patients
require more frequent tests at some point in their care,
it is also vital to involve the patient and explain reasons
for the decision.
Excessive waiting times and difﬁcultly booking
appointments were also major concerns. In particular,
patients worried that appointment cancellations could
extend the interval between tests beyond what was
recommended by the clinician, therefore leaving them
exposed to undetected disease progression. It is known
that while clinicians select appropriate monitoring inter-
vals, hospital-initiated rescheduling is a major challenge
to appropriate follow-up.7 34 35 Moreover, it was typical
for patients to wait at the clinic for hours in order to
complete multiple vision tests, causing frustration and
tiredness which some perceived to inﬂuence their subse-
quent performance. Potential solutions could involve
conducting only the VF test during short independent
appointment slots, or carrying out tests at a more con-
venient location. However, such strategies would involve
further investigation as to their overall cost-effectiveness
and should address other associated practicalities such
as travel (a signiﬁcant contributor to total patient
costs36) and the information trail back to the hospital.
Previous research has relied on statistical analysis or
computer simulations to help determine the most effect-
ive VF monitoring strategies for patients with glaucoma.
This is the ﬁrst study to use qualitative methods to inves-
tigate the patient’s own perspective on their follow-up.
Studies focusing on the patient’s perspective in glau-
coma, particularly with regard to the perceived effects of
the disease on their day-to-day activities, have typically
relied on questionnaires.13 However, questionnaire
responses can be restricted by the wording of the items
and provide little opportunity for clariﬁcation or elabor-
ation. This study allowed individuals to contextualise
their experiences and expand on particular points and
themes, encouraging discussion about topics certain
patient may not have otherwise introduced or attributed
to glaucoma without the encouragement of another.18
The notion of the ‘expert patient’ is beginning to be
endorsed with regard to other chronic conditions, with
focus groups demonstrating potential as a forum for the
development of more effective management strat-
egies.37–39 Furthermore, patient groups have aided the
development of health education programmes for
age-related macular degeneration.40 A systematic review
of patient-centred randomised controlled trials suggests
there may be some beneﬁts associated with involving
patients with chronic disease in programmes geared
towards better educating service users and devising
general training for health professionals.41 Future work
that encourages more patient’s involvement may there-
fore help devise the optimal strategies for glaucoma
follow-up and also help better inform patients and
health professionals about the condition.
This study has its limitations with ﬁndings attached to
the viewpoints of the groups who took part. Efforts were
taken to reduce bias by involving multiple research sites;
however, these were all geographically limited to the
South of England and (excluding the London groups)
involved patients of Caucasian ethnicity. Therefore, the
ﬁndings may not necessarily translate to a wider popula-
tion. Moreover, initial patient selection was made on rec-
ommendation of consultants at the clinics and our
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selection process did not monitor reasons for non-
participation. People who choose to volunteer for focus
groups are likely to be articulate and conﬁdent; they
may also be more motivated to take part due to having
more severe disease or holding strong opinions about a
certain area of their care. Furthermore, participants
were aged 60 years and older—younger service users
may have differing views and experiences that also
warrant investigation. The study was initially designed to
involve six focus groups across three locations and so no
direct decision was taken to cease data collection;
however, similar themes and subthemes continued to
emerge in the latter focus groups and so it is likely that
‘data saturation’ was achieved. Furthermore, some of the
focus groups were small (one consisting of only 3 partici-
pants) due to late cancellations but this is not a major
limitation due to the number of focus groups that took
place.42 Also, some biases could have been introduced
during interview and analysis due to the preconceived
ideas held by the experimenters about the areas of
importance, although care was taken to adhere to
expected practice by following the COREQ checklist for
focus group research.22
A number of important themes did emerge that give
an insight into clinic visits and VFs from the patient’s
perspective, and could help inform patient-centred care
in glaucoma. Although patients appeared frustrated by a
number of aspects of their follow-up, they ultimately
accepted that some compromises had to be made in
order to save their eyesight. Some of the viewpoints illu-
strated in the focus group discussions may in part
explain why research-supported guidelines about more
frequent VF testing are not being implemented effect-
ively in clinical practice. A holistic approach that
embraces patients’ opinions may therefore be vital to
help devise the most effective strategies for follow-up
care in this chronic disease.
Conclusion
This is the ﬁrst study to use qualitative methods to
examine patient’s opinion about the glaucoma clinic
experience and VF tests. Although patients found the
VF test onerous, they accepted it was important to their
overall vision assessment. However, a number of action-
able points were raised which were perceived to impact
the effectiveness of follow-up care, including distracting
testing environments, and hospital constraints relating
to excessive waiting times and appointment booking.
Some patients also expressed particular concerns about
the VF technology used and the quality of test instruc-
tions. Anxiety associated with increased testing in the
absence of clinical explanation was another theme.
Ensuring that glaucoma monitoring is carried out as
clinically and cost-effectively as possible will inevitably
require the conﬁdence and cooperation of the patient.
Addressing some or all of the perceived barriers
highlighted in this study should help deliver more efﬁ-
cient strategies for VF monitoring in glaucoma.
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